The global cancer gene therapy market was valued at USD 4.64 Billion in 2024 driven by the advancements in immune-oncology therapies across the globe. It is expected to grow at a CAGR of 18.90% during the forecast period of 2025-2034 and attain a market value of USD 26.20 Billion by 2034.
Base Year
Historical Year
Forecast Year
The increasing use of personalized therapies and advancements in gene-editing technologies such as CRISPR-Cas9 are driving the market, improving treatment accuracy and results.
Collaborations between biotech and pharmaceutical companies are focused on speeding up the progress of cancer gene therapy, showing a teamwork strategy to tackle unmet medical needs and boost market growth.
North America is leading the market, owing to its strong R&D infrastructure, government support, and the presence of major companies, which all contribute to a favorable environment for innovation.
Value in USD Billion
2025-2034
Cancer Gene Therapy Market Outlook
*this image is indicative*
Cancer gene therapy works by changing and substituting defective genes to treat or prevent cancer. The market is experiencing rapid growth, driven by CRISPR-9, rising cancer rates, and advancements in personalized medicine. Other market trends involve the integration of AI for enhanced diagnosis and increased funding to promote innovation. These various characteristics are expanding the market by offering effective solutions for previously unaddressed needs, which in turn improves research and development and promotes commercialization.
Rising Prevalence of Cancer Drives Market Growth
Due to the rising number of cancer cases worldwide, there is a growing need for new, advanced treatments. According to the American Cancer Society, 1,958,310 new cancer cases were detected, and 609,820 cancer fatalities took place in the United States in 2023. Gene therapy provides personalized and targeted treatments, addressing areas where traditional therapies are ineffective. Hence, the increasing number of patients is boosting market growth by motivating research and development as well as commercialization activities.
Several trends and developments are being observed in the market to enhance the current situation. The following are some of the noteworthy trends.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Therapy Type
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on the Indication Set to Witness Substantial Growth
Based on indication, the market is segmented into breast cancer, ovarian cancer, pancreatic cancer, lung cancer, liver cancer, prostate cancer, and others. Among these, breast cancer is the leading cancer type in the market because of its rising global incidence and the growing emphasis on targeted therapy solutions. Gene therapies for breast cancer target genetic mutations, providing personalized and efficient treatments. This led to significant funding in R&D, leading to many clinical trials and approvals.
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is projected to lead the market due to the presence of large pharmaceutical companies and significant healthcare spending. Strong research endeavors and support from the government for cancer research are helping to grow the local market.
The key features of the market report include patent analysis, clinical trials analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Based in New York, the company holds a significant presence in the immuno-oncology research domain. One of their notable products include Abecma (idecabtagene vicleucel) is a CAR T-cell therapy approved for treating relapsed or refractory multiple myeloma in the field of cancer gene therapy.
Elevate Bio Inc. is an international biotech corporation that focuses on cell and gene treatments. The headquarters of the company are in Massachusetts. Their main priority is to create and produce groundbreaking treatments for a range of illnesses, such as cancer. ElevateBio works with various partners to progress gene therapies for various types of cancer, utilizing their knowledge in gene editing and cell engineering.
The company was established in New York and is in the process of creating cell and gene therapies for severe illnesses as a clinical-stage biopharmaceutical firm. Their lineup consists of experimental gene therapies for uncommon genetic disorders and specific cancers, making use of their proficiency in adeno-associated virus (AAV) vector technologies to create focused treatments.
Bluebird Bio Inc. is an international biotech company headquartered in Massachusetts. In partnership with Bristol-Myers Squibb, they have created CAR T-cell treatments that focus on cancer markers, such as idecabtagene vicleucel (Abecma), to address multiple myeloma.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other companies include Asklepios BioPharmaceutical Inc., NantKwest, Inc., Glaxo Smith Kline Inc., and Genelux Corporation.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Therapy Type |
|
| Breakup by Indication |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share